Newsroom

INCLINE VILLAGE, Nev.--(BUSINESS WIRE)--Socure, the leading trust infrastructure for global identity and risk intelligence, and Prism Data, a top cash-flow underwriting analytics company, today announced a strategic partnership to bring market-leading cash flow analytics directly into Socure RiskOS®, Socure’s unified fraud, compliance, and risk decisioning platform. By embedding Prism’s CashScore® and intelligence suite into the Socure RiskOS ecosystem, the partnership enables lenders to move b...

NEW YORK & TORRANCE, Calif.--(BUSINESS WIRE)--Thesis Care and Unio Health Partners partner to deploy AI care team agents across Unio's California specialty practices serving 500,000+ patients....

WOODBURY, N.Y.--(BUSINESS WIRE)--BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Delphia Therapeutics, Inc. (Delphia), a biopharmaceutical company pioneering an innovative new area of cancer biology – activation lethality – which targets cancer's surprising vulnerability to oncogene overactivation, today announced the appointment of David P. Kerstein, M.D., as chief medical officer. Dr. Kerstein brings significant experience in oncology drug development across early- and late-stage precision oncology programs. “David is an accomplished phy...

NEW YORK--(BUSINESS WIRE)--BNB Plus Corp. (Nasdaq: BNBX) ("BNB Plus" or the "Company"), today announced it has secured initial commitments for $4.1M of convertible preferred stock financing, with additional commitments anticipated to bring total proceeds to $5.0M (the "Financing"). Proceeds from the Financing will be used to bolster the Company’s digital asset treasury and will provide working capital in support of a comprehensive strategic review. With the anticipated proceeds, the Company exp...

LEAWOOD, Kan.--(BUSINESS WIRE)--AMC Entertainment (NYSE: AMC), the largest theatrical exhibitor in the United States and in the world, welcomed more than 5.0 million moviegoers to its theatres across the United States and to its ODEON Cinemas locations internationally during the U.S. Memorial Day holiday weekend, spanning Thursday through Monday. At its U.S. locations, AMC enjoyed its highest-attended Thursday-through-Monday period of 2026, reflecting continued strong momentum at the box office...

NAARDEN, The Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)--Prilenia Therapeutics B.V. today announced a Data Use Agreement (DUA) under which Prilenia will provide CHDI with clinical data from the placebo arms of its PRIDE and PROOF studies for the purpose of advancing research into treatments for Huntington's disease (HD). “Collaboration which balances scientific rigor with data openness is an ethical and scientific imperative. Sharing data is key to accelerating and advancing knowledge and un...

SAN FRANCISCO--(BUSINESS WIRE)--Fastly, Inc. (NASDAQ: FSLY), a leader in global edge platforms, today announced that management will be participating in a presentation at the William Blair 46th Annual Growth Stock Conference in Chicago on June 2nd at 5:40 p.m. ET. A webcast of the presentation will be available on Fastly’s Investor Relations website at https://investors.fastly.com. About Fastly, Inc. Fastly’s powerful and programmable edge cloud platform helps the world’s top brands deliver onl...

中国北京--(BUSINESS WIRE)--(美国商业资讯)-- 百奥赛图（北京）医药科技股份有限公司（以下简称“百奥赛图”，SSE: 688796；HKEX: 02315），近日宣布正式发布 RenSuper Workstation，这一新一代 AI 驱动的抗体发现平台，面向全球合作伙伴提供可现货获取的大规模、经实验验证的全人源治疗性抗体资源，支持推动抗体发现从“定制化项目”迈向“可检索、可规模化、更高效”的新模式。 平台崛起的底座：真实全人抗体库 + AI与自动化双引擎 RenSuper Workstation的核心基础，来自百奥赛图依托自主RenMice®全人抗体小鼠平台长期积累的规模化免疫与真实数据体系。 围绕1000+潜在可成药靶点，百奥赛图开展大规模体内免疫与筛选，构建了海量真实全人抗体序列“现货分子库”。这一“真实库”与传统依赖预测模型生成的虚拟库不同，其每条序列均来源于体内免疫并经过实验验证，具备真实结合与功能证据，为抗体研发提供更可靠的源头分子资产。 在此基础上，RenSuper将大规模体内免疫、下一代测序（NGS）、AI驱动的高通量筛选、实验验证整合为统一工作流，...

NEW YORK--(BUSINESS WIRE)--Pagaya Technologies LTD. (NASDAQ: PGY) ("Pagaya" or the “Company”), a global technology company delivering AI-driven product solutions for the financial ecosystem, today announced the closing of RPM 2026-3, a $600 million upsized auto asset-backed securitization (ABS). This marks Pagaya’s third fully pre-funded auto ABS transaction of 2026 and its largest to date, bringing the total amount of pre-funded auto ABS raised this year to $1.5 billion. “We are encouraged by...